Form 4: Myomo Director Thomas Kirk Increases Stake with Open Market Purchases

Director Thomas Kirk increased his holdings in Myomo, Inc. through open market purchases on May 14-15, 2025.

Summary

• Thomas F. Kirk, a director of Myomo, Inc., reported purchasing shares of common stock in the open market.
• On May 14, 2025, he acquired 1,943 shares at a price of $3.25 per share.
• On May 15, 2025, he purchased an additional 36,824 shares, also at $3.25 per share.
• Following these transactions, Kirk directly owns 344,700 shares of Myomo, Inc. common stock.
• Kirk has granted a limited power of attorney to Paul Gudonis, David Henry, and Amy Vetrano-Palmer to execute SEC filings on his behalf.

Sentiment

Score: 6

Explanation: Insider buying is generally viewed as a positive sign, but the impact is moderate as it's a single director's activity and the amounts are not exceptionally large relative to the company's size.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Insider buying is often monitored as an indicator of management's sentiment about the company's prospects, but it's important to consider the individual's overall holdings and past trading activity.

Comparison to Industry Standards

• Comparing insider trading activity to similar companies in the medical device industry can provide context, but each situation is unique.
• It's important to consider the size of the purchases relative to Kirk's existing holdings and the overall market capitalization of Myomo.

Stakeholder Impact

• Shareholders may view the director's stock purchase as a positive signal.
• The impact on other stakeholders is likely minimal.

Key Dates

Keywords

Myomo, insider trading, Form 4, beneficial ownership, Thomas Kirk, stock purchase, director, MYO